| Breakdown | TTM | Mar 2024 | Mar 2023 | Sep 2022 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.05M | 14.11M | 22.03M | 16.88M | 8.07M | 7.39M |
| Gross Profit | -590.58K | 12.21M | 7.85M | 2.60M | 2.93M | 3.17M |
| EBITDA | -8.63M | -26.21M | -33.33M | -4.15M | 1.83M | 1.29M |
| Net Income | -31.46M | -33.74M | -36.88M | -5.38M | -3.90M | 1.48M |
Balance Sheet | ||||||
| Total Assets | 19.24M | 22.08M | 86.67M | 38.82M | 25.96M | 8.95M |
| Cash, Cash Equivalents and Short-Term Investments | 5.85M | 11.78M | 20.34M | 10.59M | 23.42M | 4.31M |
| Total Debt | 4.61M | 3.88M | 40.42M | 5.50M | 6.32M | 1.27M |
| Total Liabilities | 17.63M | 16.33M | 55.09M | 7.79M | 6.96M | 4.04M |
| Stockholders Equity | 1.61M | 5.75M | 31.58M | 31.03M | 19.01M | 4.91M |
Cash Flow | ||||||
| Free Cash Flow | -6.53M | -9.85M | 4.64M | -6.05M | -420.92K | -2.64M |
| Operating Cash Flow | -6.53M | -9.30M | 7.44M | -5.98M | -348.92K | -2.57M |
| Investing Cash Flow | 455.88K | 195.14K | -2.67M | -7.03M | -72.00K | -607.71K |
| Financing Cash Flow | -30.15K | 1.41M | 4.59M | -1.20M | 20.07M | -828.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £155.07M | 6.83 | 104.64% | 7.02% | -4.35% | 5.34% | |
69 Neutral | £46.23M | -5.27 | -9.07% | ― | 6.40% | 70.78% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | £754.75M | 413.34 | 3.98% | ― | -0.85% | ― | |
56 Neutral | £35.14M | -11.38 | 31.19% | ― | 25.15% | ― | |
49 Neutral | £1.92M | -1.55 | ― | ― | ― | ― |